news aktuell GmbH

4ARTechnologies: Market Leader in Art Security and Digitization Develops the World's First Secure NFT for Physical and Digital Artworks

5.5.2021 09:00:00 CEST | news aktuell GmbH | Press release

Share

(Zug, Switzerland): 4ARTechnologies, the market leader in art security and digitization announces the next sensation: "We give art creators and collectors the exclusive opportunity to create the world's only secure NFT with our technology." - CEO Niko Kipouros. 

We are witnessing the next chapter in art history with NFTs- Beeple sold a digital work for nearly USD 70 million. Cryptopunks, initially generated for free, are now worth millions. 

Experienced art & technology specialist 4ARTechnologies is now expanding its patented all-in-one solution for the highly complex NFT landscape. The technology has already brought a revolution for security, efficiency and transparency to the global art industry since 2019 and already accompanies challenging projects with leading institutions such as Munich RE, Ergo Insurance, AON and hasenkamp.

With the new expansion, the company offers the safest and easiest entry into the world of NFTs for any of the more than 25 million creating art players worldwide to swiftly position themselves in the new market and thereby profit in the long term.

Among the new unique features for the art market are: the innovative creation and securing of an NFT at the touch of a button, managing and presenting one's own art collection in a dedicated virtual showroom for unparalleled and secure marketing and connecting popular blockchain protocols such as Ethereum and Tezos.

About 4ARTechnologies

With the goal of protecting the cultural heritage of art for future generations and bringing the global art market into the digital age, 4ARTechnologies is setting a new digital standard for the art world. The company combines the blockchain with its patented technology and offers all art world participants more transparency, security and efficiency.

https://www.4art-technologies.com/services

Contacts

4ARTechnologies AG
Dino Lewkowicz
dino@4art-technologies.com
Mobile: +41 41 740 00 50
www.4art-technologies.com

Images

About news aktuell GmbH

news aktuell GmbH
news aktuell GmbH
Mittelweg 144
20148 Hamburg

+49 (0)40 4113-32589http://www.newsaktuell.de

news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.

Subscribe to releases from news aktuell GmbH

Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from news aktuell GmbH

Grünenthal licenses exclusive South Korean rights to Qutenza® to BCWorld Pharm5.3.2026 08:54:06 CET | Press release

Aachen, Germany & Yeoju, South Korea, 5 March 2026 – Grünenthal, a global leader in pain management and related diseases, and BCWorld Pharm Co., Ltd. ("BCWP"), a specialty company actively expanding and diversifying its pain management portfolio through global open innovation partnerships, announced today that they have entered into a definitive agreement whereby BCWP will have the exclusive South Korean rights to Qutenza®, a topical, non-systemic, non-opioid patch treatment. In Europe, the product is indicated for the management of peripheral neuropathic pain.

Grünenthal takes full ownership of Grünenthal Meds, the joint venture established with Kyowa Kirin for its established medicines brands2.3.2026 10:39:09 CET | Press release

Grünenthal acquired Kyowa Kirin International’s 49% stake in ‘Grünenthal Meds’, a joint venture formed in 2023 to market the established medicines portfolio from Kyowa Kirin International. Through this acquisition, Grünenthal assumes the sole responsibility of a portfolio comprising 12 brands across six therapeutic areas and >60 markets.

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye